Profiling of patients with glioma reveals the dominant immunosuppressive axis is refractory to immune function restoration.
Profiling of patients with glioma reveals the dominant immunosuppressive axis is refractory to immune function restoration. JCI Insight. 2020 09 03; 5(17).